2022-500137-89-00终止3 期
Vasopressin and Steroids in addition to Adrenaline in cardiac arrest -a randomized clinical trial
Tiohundra AB3 个研究点 分布在 1 个国家目标入组 1,400 人开始时间: 2022年3月28日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 发起方
- 入组人数
- 1,400
- 试验地点
- 3
- 主要终点
- Survival at 30 days
研究概览
简要总结
The primary objective of the study is to determine whether the use of a combination of adrenaline, vasopressin and steroids will increase 30 days survival in cardiac arrest patients compared to standard adrenaline alone
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- •In hospital cardiac arrest patients meeting criteria for adrenaline administration according to current ERC guidelines are eligible for the study
排除标准
- •Patient under 18 years of age, Women considered of childbearing potential (WOCBP) i. e. premenopausal women
结局指标
主要结局
Survival at 30 days
Survival at 30 days
次要结局
未报告次要终点
研究者
Sune Forsberg
Scientific
Tiohundra AB
研究点 (3)
Loading locations...
相似试验
招募中
3 期
VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical TrialCardiac Arrest;In-hospital Cardiac Arrest; Methylprednisolone; Vasopressin; Adrenaline; Randomized Clinical TrialNCT05139849Tiohundra AB1,276
进行中（未招募）
1 期
VAsopressin and STeroids in addition to Adrenaline in cardiac arrest-a randomized clinical trial. VAST-ACardiac arrestCTIS2022-500137-89-00Tiohundra AB1,400
进行中（未招募）
1 期
Vasopressin and steroids in addition to adrenaline in cardia arrest in hospitalTreatment of ST-elevated myocardial infarction (STEMI) after percutaneous intervention (PCI)MedDRA version: 20.0Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10064346Term: STEMISystem Organ Class: 10007541 - Cardiac disordersEUCTR2019-002310-39-SEorrtälje Sjukhus, Tiohundra AB82
已完成
3 期
Vasopressin, Epinephrine, and Steroids for Cardiac ArrestCardiac ArrestNCT00729794University of Athens300
招募中
4 期
Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill PatientsCirculatory ShockNCT06265259University of Thessaly145